-
If you assume that patients complaining of headache are nontherapeutic medication seekers or chronic complainers, you risk undertriaging these patients, warns Rebekah Child, RN, MSN, CEN, CNIV, an ED nurse at Cedars-Sinai Medical Center in Los Angeles.
-
An elderly woman tells ED triage nurses she's had an excruciating, unrelenting headache for the past two days. She has a steady gait.
-
Gilbert (AZ) Hospital has one of the busiest emergency departments in the area and an average ED waiting time of less than 12 minutes.
-
The Centers for Medicare & Medicaid Services (CMS) has proposed significant expansion in hospital quality reporting requirements, including adding 46 new quality measures for which hospitals must submit data over the next two years, and increasing the number of hospital-acquired conditions for which Medicare won't reimburse.
-
Faced with an increasing number of patients in observation status, Brandon (FL) Regional Hospital began an observation management process that resulted in a 16% decrease in observation patients and a 27% drop in observation length of stay in just one year.
-
A new generation of physicians is reinvigorating the field of cardiac arrest research. I am grateful that two of the experts in this area have written this issue of EM Reports. After reading this, I anticipate you will place these principles into practice.
-
The American Public Health Association (APHA) has just issued a policy statement calling for schools of public health, pharmacy, and medicine to include specific education around the adverse impact of douching on reproductive and maternal outcomes.
-
While women now have more contraceptive options, many still struggle with achieving success with their chosen contraceptive method. What can clinicians do to improve method success?
-
Your next patient is a healthy, fit 45-year-old nonsmoking woman. She says her menstrual periods are now less regular, and she reports having intermittent hot flashes. Newly divorced, she is now sexually active and wonders which contraceptive is right for her. What's your recommendation?
-
Use of the cervical cancer vaccine may soon expand: Merck has filed with the Food and Drug Administration (FDA) for use of Gardasil (Merck & Co.; Whitehouse Station, NJ) in use in women ages 27 through 45.
